Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $BLTE vs $DFTX | Chartloom

Compare

$BLTE vs $DFTX

Belite Bio Inc · Definium Therapeutics Inc

BLTE

Belite Bio Inc

DFTX

Definium Therapeutics Inc

Compare $BLTE vs $DFTX

Comparing Belite Bio Inc and Definium Therapeutics Inc

BLTEBelite Bio Inc

DFTXDefinium Therapeutics Inc

BLTEBelite Bio Inc

Market cap

$5.70B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

21.92x

Rev growth (TTM)

—

YTD performance

-4.6%

52W performance

91.6%

FCF yield

0.0%

DFTXDefinium Therapeutics Inc

Market cap

$4.28B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

152.1%

52W performance

191.1%

FCF yield

-3.9%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BLTE

DFTX

Detailed metrics comparison

BLTE

Belite Bio Inc

DFTX

Definium Therapeutics Inc

Market Cap

BLTE$5.70B

DFTX$4.28B

Enterprise Value

BLTE$5.70B

DFTX$3.67B

Price

BLTE$151.87

DFTX$34.38

P/E Ratio

BLTEN/A

DFTXN/A

P/S Ratio

BLTE0.00x

DFTX0.00x

EV/Sales

BLTE0.00x

DFTX0.00x

EV/EBITDA

BLTE0.00x

DFTX0.00x

P/B Ratio

BLTE7.97x

DFTX5.40x

P/FCF Ratio

BLTEN/A

DFTXN/A

EV/FCF

BLTE0.00x

DFTX-21.83x

PEG Ratio

BLTEN/A

DFTXN/A

Forward P/E (NTM)

BLTEN/A

DFTXN/A

Forward P/S (NTM)

BLTE21.92x

DFTXN/A

Revenue (TTM)

BLTE$0

DFTX$0

Revenue Growth (YoY)

BLTEN/A

DFTXN/A

Forward Rev Growth

BLTE97.1%

DFTX717.7%

Gross Margin (TTM)

BLTE0.0%

DFTX0.0%

Operating Margin (TTM)

BLTE0.0%

DFTX0.0%

EBITDA Margin (TTM)

BLTE0.0%

DFTX0.0%

Net Margin (TTM)

BLTE0.0%

DFTX0.0%

FCF Margin (TTM)

BLTEN/A

DFTXN/A

Net Income (TTM)

BLTE$-116M

DFTX$-354M

FCF (TTM)

BLTE$0

DFTX$-168M

EPS (TTM)

BLTE-$3.07

DFTX-$3.20

ROE (TTM)

BLTE-2687.0%

DFTX-8523.0%

ROA (TTM)

BLTE-2626.0%

DFTX-6458.0%

ROIC (TTM)

BLTE-2687.0%

DFTX-7781.0%

Cash

BLTE$0

DFTX$655M

Debt

BLTE$0

DFTX$36M

Net Cash/Debt

BLTE$0

DFTX$619M

Current Ratio (TTM)

BLTE50.02x

DFTX6.95x

Quick Ratio (TTM)

BLTE49.90x

DFTX6.89x

Debt/Equity (TTM)

BLTE0.00x

DFTX0.04x

Debt/Assets (TTM)

BLTE0.0%

DFTX0.0%

Interest Coverage (TTM)

BLTEN/A

DFTXN/A

Net Debt/EBITDA (TTM)

BLTE0.00x

DFTX0.00x

Beta

BLTE-1.22

DFTX2.23

52W Performance

BLTE91.6%

DFTX191.1%

YTD Performance

BLTE-4.6%

DFTX152.1%

% from 52W High

BLTE-24.1%

DFTX-30.8%

% from 52W Low

BLTE92.9%

DFTX228.5%

Asset Turnover (TTM)

BLTE0.00x

DFTX0.00x

FCF Yield (TTM)

BLTE0.0%

DFTX-3.9%

Earnings Yield (TTM)

BLTE-2.0%

DFTX-8.3%

Dividend Yield (TTM)

BLTEN/A

DFTXN/A

Rule of 40

BLTE0.0

DFTX0.0

EV/GP/RG

BLTEN/A

DFTXN/A

Ticker research

View BLTE research View DFTX research

Metric	BLTE Belite Bio Inc	DFTX Definium Therapeutics Inc
Market & Valuation
Market Cap	$5.70B	$4.28B
Enterprise Value	$5.70B	$3.67B
Price	$151.87	$34.38
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	7.97x	5.40x
P/FCF Ratio	N/A	N/A
EV/FCF	0.00x	-21.83x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	21.92x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	97.1%	717.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-116M	$-354M
FCF (TTM)	$0	$-168M
EPS (TTM)	-$3.07	-$3.20
ROE (TTM)	-2687.0%	-8523.0%
ROA (TTM)	-2626.0%	-6458.0%
ROIC (TTM)	-2687.0%	-7781.0%
Financial Health
Cash	$0	$655M
Debt	$0	$36M
Net Cash/Debt	$0	$619M
Current Ratio (TTM)	50.02x	6.95x
Quick Ratio (TTM)	49.90x	6.89x
Debt/Equity (TTM)	0.00x	0.04x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.22	2.23
52W Performance	91.6%	191.1%
YTD Performance	-4.6%	152.1%
% from 52W High	-24.1%	-30.8%
% from 52W Low	92.9%	228.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	0.0%	-3.9%
Earnings Yield (TTM)	-2.0%	-8.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BLTE research	View DFTX research

Valuation

P/S Ratio

BLTE

0.00x

DFTX

0.00x

EV/FCF

DFTX

-21.83x

BLTE

0.00x

Growth & revenue

Forward Revenue Growth

DFTX

717.7%

BLTE

97.1%

Profitability & performance

Gross Margin

BLTE

0.0%

DFTX

0.0%

ROE

BLTE

-2687.0%

DFTX

-8523.0%

FCF Yield %

BLTE

0.0%

DFTX

-3.9%

52-Week Performance

DFTX

191.1%

BLTE

91.6%

Detailed metrics comparison

BLTE

Belite Bio Inc

DFTX

Definium Therapeutics Inc

Market Cap

BLTE$5.70B

DFTX$4.28B

Enterprise Value

BLTE$5.70B

DFTX$3.67B

Price

BLTE$151.87

DFTX$34.38

P/E Ratio

BLTEN/A

DFTXN/A

P/S Ratio

BLTE0.00x

DFTX0.00x

EV/Sales

BLTE0.00x

DFTX0.00x

EV/EBITDA

BLTE0.00x

DFTX0.00x

P/B Ratio

BLTE7.97x

DFTX5.40x

P/FCF Ratio

BLTEN/A

DFTXN/A

EV/FCF

BLTE0.00x

DFTX-21.83x

PEG Ratio

BLTEN/A

DFTXN/A

Forward P/E (NTM)

BLTEN/A

DFTXN/A

Forward P/S (NTM)

BLTE21.92x

DFTXN/A

Revenue (TTM)

BLTE$0

DFTX$0

Revenue Growth (YoY)

BLTEN/A

DFTXN/A

Forward Rev Growth

BLTE97.1%

DFTX717.7%

Gross Margin (TTM)

BLTE0.0%

DFTX0.0%

Operating Margin (TTM)

BLTE0.0%

DFTX0.0%

EBITDA Margin (TTM)

BLTE0.0%

DFTX0.0%

Net Margin (TTM)

BLTE0.0%

DFTX0.0%

FCF Margin (TTM)

BLTEN/A

DFTXN/A

Net Income (TTM)

BLTE$-116M

DFTX$-354M

FCF (TTM)

BLTE$0

DFTX$-168M

EPS (TTM)

BLTE-$3.07

DFTX-$3.20

ROE (TTM)

BLTE-2687.0%

DFTX-8523.0%

ROA (TTM)

BLTE-2626.0%

DFTX-6458.0%

ROIC (TTM)

BLTE-2687.0%

DFTX-7781.0%

Cash

BLTE$0

DFTX$655M

Debt

BLTE$0

DFTX$36M

Net Cash/Debt

BLTE$0

DFTX$619M

Current Ratio (TTM)

BLTE50.02x

DFTX6.95x

Quick Ratio (TTM)

BLTE49.90x

DFTX6.89x

Debt/Equity (TTM)

BLTE0.00x

DFTX0.04x

Debt/Assets (TTM)

BLTE0.0%

DFTX0.0%

Interest Coverage (TTM)

BLTEN/A

DFTXN/A

Net Debt/EBITDA (TTM)

BLTE0.00x

DFTX0.00x

Beta

BLTE-1.22

DFTX2.23

52W Performance

BLTE91.6%

DFTX191.1%

YTD Performance

BLTE-4.6%

DFTX152.1%

% from 52W High

BLTE-24.1%

DFTX-30.8%

% from 52W Low

BLTE92.9%

DFTX228.5%

Asset Turnover (TTM)

BLTE0.00x

DFTX0.00x

FCF Yield (TTM)

BLTE0.0%

DFTX-3.9%

Earnings Yield (TTM)

BLTE-2.0%

DFTX-8.3%

Dividend Yield (TTM)

BLTEN/A

DFTXN/A

Rule of 40

BLTE0.0

DFTX0.0

EV/GP/RG

BLTEN/A

DFTXN/A

Ticker research

View BLTE research View DFTX research

Metric	BLTE Belite Bio Inc	DFTX Definium Therapeutics Inc
Market & Valuation
Market Cap	$5.70B	$4.28B
Enterprise Value	$5.70B	$3.67B
Price	$151.87	$34.38
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.00x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	7.97x	5.40x
P/FCF Ratio	N/A	N/A
EV/FCF	0.00x	-21.83x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	21.92x	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	97.1%	717.7%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-116M	$-354M
FCF (TTM)	$0	$-168M
EPS (TTM)	-$3.07	-$3.20
ROE (TTM)	-2687.0%	-8523.0%
ROA (TTM)	-2626.0%	-6458.0%
ROIC (TTM)	-2687.0%	-7781.0%
Financial Health
Cash	$0	$655M
Debt	$0	$36M
Net Cash/Debt	$0	$619M
Current Ratio (TTM)	50.02x	6.95x
Quick Ratio (TTM)	49.90x	6.89x
Debt/Equity (TTM)	0.00x	0.04x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-1.22	2.23
52W Performance	91.6%	191.1%
YTD Performance	-4.6%	152.1%
% from 52W High	-24.1%	-30.8%
% from 52W Low	92.9%	228.5%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.00x
FCF Yield (TTM)	0.0%	-3.9%
Earnings Yield (TTM)	-2.0%	-8.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View BLTE research	View DFTX research